Pietropaolo-Cienfuegos DR, Labra-Zamora MG, Dies-Suárez P, Cabrera-Muñoz ML

Idioma: Español
Referencias bibliográficas: 16
Paginas: 308-318
Archivo PDF: 889.40 Kb.

FRAGMENTO

Paciente masculino de cinco meses de edad llevado a la consulta externa por presentar evacuaciones disminuidas de consistencia con moco y sangre acompañadas de fiebre de 38-39°C.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mattei P. Surgical Directives: Pediatric Surgery. Philadelphia: Lippincott Williams & Wilkins; 2003. pp. 313-316. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1-45.

2. Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004;23:635-641.

3. Marciano BE, Rosenzweig SD, Kleiner DE, Anderson VL, Darnell DN, Anaya-O’Brien S, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004;114:462-468.

4. Baraff LJ, Schriger DL, Bass JW, Fleisher GR, Klein JO, Mc-Cracken GH, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics 1993;92;1-12.

5. Feigin RD, Cherry JD, Kaplan SL, Demmler-Harrison G. Textbook of Pediatric Infectious Diseases. Volume 2. Philadelphia: Saunders Elsevier; 2009. pp. 1444.

6. Kliegman R, Jenson HB, Behrman RE, Stanton BF. Nelson Textbook of Pediatrics. Philadelphia: Saunders Elsevier; 2007. pp. 904-909.

7. Dinauer MC. Chronic granulomatous disease and other disorders of phagocyte function. Hematology Am Soc Hematol Educ Program 2005:89-95.

8. Assari T. Chronic granulomatous disease; fundamental stages in our understanding of CGD. Med Immunol 2006;5:4.

9. Seger RA. Chronic granulomatous disease: recent advances in pathophysiology and treatment. Neth J Med 2010;68:334-340.

10. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 2003;15:578-584.

11. Goldblatt D, Thrasher AJ. Chronic granulomatous disease. Clin Exp Immunol 2000;122:1-9.

12. Segal BH, Leto TL, Gallin JJ, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000;79:170-200.

13. Oliveira JB, Fleisher TA. Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol 2010;125(suppl. 2):S297-S305.

14. Landing BH, Shirley HS. A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes. Pediatrics 1957;20:431-438.

15. Stasia MJ, Li XJ. Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol 2008;30:209-235.

16. Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010;363:2600-2610.